70 related articles for article (PubMed ID: 19609842)
1. Increased percentage of microvessels but decreased density of large vessels in papillary carcinomas as compared to hot and cold thyroid nodules.
Sancak S; Hardt A; Ricken A; Lorenz S; Eszlinger M; Sen LS; Güllüoglu BM; Sever Z; Eren FT; Akalin NS; Paschke R
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):637-44. PubMed ID: 19609842
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor 2 expression determined by immunohistochemistry in cold thyroid nodules exceeds that of hot thyroid nodules, papillary thyroid carcinoma, and Graves' disease.
Sancak S; Hardt A; Singer J; Klöppel G; Eren FT; Güllüoglu BM; Sen LS; Sever Z; Akalin NS; Eszlinger M; Paschke R
Thyroid; 2010 May; 20(5):505-11. PubMed ID: 20450431
[TBL] [Abstract][Full Text] [Related]
3. [Expression of MMP-9 and CD34 in papillary thyroid carcinomas].
Zhang HB; Wei QY
Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):427-8. PubMed ID: 14653139
[No Abstract] [Full Text] [Related]
4. Angioarchitecture of thyroid carcinoma.
Watanabe I; Matsuura K
Jpn J Clin Oncol; 1985 Mar; 15(1):77-85. PubMed ID: 2580109
[TBL] [Abstract][Full Text] [Related]
5. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV
Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
[TBL] [Abstract][Full Text] [Related]
6. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease?
Anderson SR; Mandel S; LiVolsi VA; Gupta PK; Baloch ZW
Diagn Cytopathol; 2004 Jul; 31(1):64-7. PubMed ID: 15236269
[TBL] [Abstract][Full Text] [Related]
7. CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto's thyroiditis.
Anderson CE; Graham C; Herriot MM; Kamel HM; Salter DM
Histopathology; 2009 Dec; 55(6):683-6. PubMed ID: 19922591
[TBL] [Abstract][Full Text] [Related]
8. Intermediate microRNA expression profile in Graves' disease falls between that of normal thyroid tissue and papillary thyroid carcinoma.
Pohl M; Grabellus F; Worm K; Arnold G; Walz M; Schmid KW; Sheu-Grabellus SY
J Clin Pathol; 2017 Jan; 70(1):33-39. PubMed ID: 27371612
[TBL] [Abstract][Full Text] [Related]
9. Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance.
Akslen LA; Livolsi VA
Hum Pathol; 2000 Apr; 31(4):439-42. PubMed ID: 10821490
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density.
Nagura S; Katoh R; Miyagi E; Shibuya M; Kawaoi A
Hum Pathol; 2001 Jan; 32(1):10-7. PubMed ID: 11172289
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
de la Torre NG; Buley I; Wass JA; Turner HE
Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
[TBL] [Abstract][Full Text] [Related]
12. Computerized nuclear morphometry and quantitation of angiogenesis in thyroid neoplasms.
Kavantzas N; Tseleni-Balafouta S; Davaris P
J Exp Clin Cancer Res; 2002 Jun; 21(2):247-54. PubMed ID: 12148586
[TBL] [Abstract][Full Text] [Related]
13. Microspectrophotometric measurements of deoxyribonucleic acid in human thyroid carcinomas.
Lindsay S
Surg Gynecol Obstet; 1970 Nov; 131(5):905-13. PubMed ID: 4097241
[No Abstract] [Full Text] [Related]
14. Apolipoprotein e expression in anaplastic thyroid carcinoma.
Ito Y; Takano T; Miyauchi A
Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
[TBL] [Abstract][Full Text] [Related]
15. Analysis of lectin binding in benign and malignant thyroid nodules.
Sasano H; Rojas M; Silverberg SG
Arch Pathol Lab Med; 1989 Feb; 113(2):186-9. PubMed ID: 2916907
[TBL] [Abstract][Full Text] [Related]
16. Recurrent thyroid cancers have more peritumoural lymphatic vasculature than nonrecurrent thyroid cancers.
Hakala T; Sand J; Kellokumpu-Lehtinen PL; Huhtala H; Leinonen R; Kholová I
Eur J Clin Invest; 2014 Sep; 44(9):825-32. PubMed ID: 25047155
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
[TBL] [Abstract][Full Text] [Related]
18. Pathologic features of Hashimoto's-associated papillary thyroid carcinomas.
Di Pasquale M; Rothstein JL; Palazzo JP
Hum Pathol; 2001 Jan; 32(1):24-30. PubMed ID: 11172291
[TBL] [Abstract][Full Text] [Related]
19. Confocal laser scanning microscopic observation of angioarchitectures in human thyroid neoplasms.
Katoh R; Hemmi A; Komiyama A; Kawaoi A
Hum Pathol; 1999 Oct; 30(10):1226-31. PubMed ID: 10534172
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-2 free from extracellular matrix is increased in papillary thyroid carcinomas and Graves' thyroids.
Emoto N; Onose H; Sugihara H; Minami S; Shimizu K; Wakabayashi I
Thyroid; 1998 Jun; 8(6):491-7. PubMed ID: 9669286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
